Quanterix to Participate in the Canaccord MedTech, Diagnostics and Digital Health & Services Forum

Author's Avatar
Nov 10, 2022

Quanterix+Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that President and Chief Executive Officer Masoud Toloue and Chief Financial Officer Michael Doyle will present at the CG+MedTech%2C+Diagnostics+and+Digital+Health+%26amp%3B+Services+Forum on Thursday, November 17, 2022 at 4:30 p.m. EST in Boston, MA. Toloue will also host one-on-one and group meetings with institutional investors that day.